The FDA approved tirzepatide for the treatment of type 2 diabetes on May 13, 2022
Mariam Sardar, PharmD
Advertisement
Articles by Mariam Sardar, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Current and Emerging BCMAxCD3 Bispecifics
3
Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab
4
Evolocumab Reduces Risk of Major Events in Patients Without Prior Cardiovascular History
5
